HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $55 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Belite Bio (NASDAQ:BLTE) and maintained a price target of $55.
July 25, 2023 | 10:19 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Belite Bio's stock may see positive movement as HC Wainwright & Co. maintains a 'Buy' rating and a price target of $55.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, the 'Buy' rating and $55 price target from HC Wainwright & Co. for Belite Bio indicates a positive outlook for the company's stock. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100